98%
921
2 minutes
20
Background The prognostic implications of middle neck involvement, defined as cervical lymph node metastasis between the caudal border of the hyoid bone and the cricoid cartilage, remain unclear in nasopharyngeal carcinoma (NPC). Purpose To investigate the prognostic significance of middle neck involvement in patients with N1 or N2 NPC. Materials and Methods This retrospective analysis included patients with N1 or N2 NPC without distant metastasis treated between April 2009 and December 2017. Patients were categorized according to the presence or absence of middle neck involvement, as determined at MRI. Survival analysis was performed by incorporating TN category and middle neck involvement. Kaplan-Meier curves and the log-rank test were used to compare survival outcomes. Results This study included 9795 patients (mean age, 45 years ± 11 [SD]; 7135 male). Middle neck involvement was identified in 17.0% of patients (1668 of 9795), with prevalence rates of 11.4% (848 of 7429) in the N1 subgroup and 34.7% (820 of 2366) in the N2 subgroup. Multivariable analysis revealed that middle neck involvement was an independent prognostic factor for reduced metastasis-free survival (MFS), overall survival (OS), and disease-free survival (DFS) in both the N1 (all < .001) and N2 subgroups ( = .001, .02, and .04, respectively). Patients with T1-T2 N1 NPC with middle neck involvement exhibited survival outcomes comparable to those in patients with T1-T2 N2 NPC (all > .05). Conversely, patients with T3N1 disease without middle neck involvement had better 5-year MFS (91.7% vs 84.6%; < .001), OS (90.6% vs 84.3%; = .003), and DFS (83.6% vs 74.4%; < .001) than those with middle neck involvement. Conclusion Middle neck involvement serves as a critical factor for risk stratification in N1 and N2 NPC. It helps identify patients at high risk within the T1-T2 N1 subgroup and those with T3N1 disease. © RSNA, 2025 See also the editorial by Jabehdar Maralani and Kang in this issue.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1148/radiol.243399 | DOI Listing |
Int J Radiat Oncol Biol Phys
September 2025
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Department of Health Services Research, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Nursing, Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Melbourne,
Purpose: This study examined head and neck cancer treatment outcome priorities in patients with human papillomavirus-associated oropharyngeal cancer (HPVOPC) before and 12 months (12m) after (chemo)radiotherapy ([C]RT).
Methods And Materials: Eligible patients were diagnosed with HPVOPC suitable for curative-intent primary [C]RT. Study data included responses to a modified version of the Chicago Priorities Scale (CPS-modified) and select items from the MDASI Head and Neck Cancer Module (MDASI-HN).
Auris Nasus Larynx
September 2025
Department of Otolaryngology, Deafness and Middle Ear Surgicenter Tokyo Kita Medical Center, 4-17-56 Akabanedai, Kita-ku, Tokyo 115-0053, Japan; Department of Otolaryngology, Head and Neck Surgery, Jichi University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama 330-0834, Japan.
Objective: This study aimed to evaluate the effect of age at tympanostomy tube insertion on mastoid air cell development, focusing on whether insertion before 3 years of age is associated with more favorable pneumatization.
Methods: We retrospectively analyzed 39 children (71 ears) who developed tympanic membrane perforation following tube insertion (tube group), including cases primarily associated with recurrent acute otitis media (rAOM) and otitis media with effusion (OME). The control group consisted of 41 children (41 ears) with congenital cholesteatoma, using their contralateral normal ears as controls.
Ann Plast Surg
September 2025
Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN.
Background: The generation of intelligible speech is the single most important outcome after cleft palate repair. The development of velopharyngeal dysfunction (VPD) compromises the outcome, and the burden of VPD remains largely unknown in low- and middle-income countries (LMICs). To scale up VPD care in these areas, we continue to explore the use of artificial intelligence (AI) and machine learning (ML) for automatic detection of VPD from speech samples alone.
View Article and Find Full Text PDFJ Opioid Manag
September 2025
HealthPartners Institute, Bloomington, Minnesota.
Objective: To evaluate the effectiveness of an outpatient, interdisciplinary pain management (IPM) program offering individualized opioid tapering as part of flexible, patient-specific care plans, in achieving the dual goals of improved management of chronic nonmalignant pain (CNMP) and substantial reduction of opioid use.
Design: A retrospective cohort study, comprising a cohort of patients who presented on opioid therapy and a cohort who did not.
Setting: Community outpatient IPM program.
Glob Health Action
December 2025
Department of Speech-language Pathology and Audiology, University of Pretoria, Pretoria, South Africa.
Background: Hearing loss affects more than 1.5 billion people worldwide, yet fewer than 10% of those who could benefit from hearing aids are able to access them. Barriers such as high costs, limited availability, and a critical shortage of trained professionals in low- and middle-income countries contribute to this gap, while emerging models of care-such as task-shifting to community healthcare workers (CHWs) supported by mHealth technologies-show promise in improving access, affordability, and outcomes in underserved communities.
View Article and Find Full Text PDF